share_log

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months

'大空'投資者邁克爾·伯裏的中國賭注得以實現,其前幾名選擇在兩個月內飆升近60%。
Benzinga ·  2024/10/09 05:19

Michael Burry, the investor renowned for his prescient bet against the housing market before the 2008 financial crisis, has seen his recent wager on Chinese stocks yield significant returns.

邁克爾·伯裏(Michael Burry)以在2008年金融危機之前對房地產市場進行有先見之明的押注而聞名,他最近對中國股票的押注帶來了可觀的回報。

What Happened: Burry's top three Chinese holdings have surged an average of 59.39% within two months, according to regulatory filings and market data.

發生了什麼:根據監管文件和市場數據,Burry在中國前三大持股量在兩個月內平均飆升了59.39%。

Burry's hedge fund, Scion Asset Management, made substantial changes to its portfolio in the second quarter of 2024. The fund's latest 13F report, filed with the U.S. Securities and Exchange Commission on Aug. 14, revealed a notable shift toward Chinese tech giants.

伯裏的對沖基金Scion Asset Management在2024年第二季度對其投資組合進行了重大調整。該基金於8月14日向美國證券交易委員會提交的最新13F報告顯示,向中國科技巨頭的顯著轉變。

Alibaba Group Holding Ltd., Burry's largest Chinese position with 155,000 shares, saw its stock price climb from $73.40 on the filing date to a peak of $117.52 on Monday — a 60.11% increase. The stock has since retreated to $91.94 amid a broader sell-off in Chinese equities.

阿里巴巴集團控股有限公司是巴里最大的中國頭寸,持有15.5萬股,其股價從申報日的73.40美元攀升至週一的117.52美元的峯值,漲幅爲60.11%。此後,由於中國股市出現更廣泛的拋售,該股已回落至91.94美元。

Baidu Inc., in which Scion holds 75,000 shares, experienced a 36.29% surge from $83.99 to a Monday high of $114.47. It now trades at $106.01.

Scion持有7.5萬股股票的百度公司從83.99美元上漲了36.29%,至週一的高點114.47美元。它現在的交易價格爲106.01美元。

JD.com Inc., representing Burry's third-largest Chinese bet with 250,000 shares, skyrocketed 81.78% from $25.90 to $47.08 before settling at $43.54.

京東公司是Burry的中國第三大賭注,擁有25萬股股票,從25.90美元飆升了81.78%,收於43.54美元。

The impressive gains in these Chinese stocks stand in stark contrast to the performance of Burry's American holdings. Molina Healthcare Inc. has dropped 4.11% over the same period, while Shift4 Payments Inc. has risen a more modest 13.26%.

這些中國股票的驚人漲幅與Burry在美國持股的表現形成鮮明對比。同期,莫利納醫療公司下跌了4.11%,而Shift4 Payments Inc.的漲幅更爲溫和,爲13.26%。

Why It Matters: Burry's pivot to Chinese equities came just before a significant rally in the sector, fueled by expectations of government stimulus. However, the rally faltered on Monday when Beijing's announced measures fell short of market expectations.

爲何重要:在政府刺激措施的預期推動下,伯裏轉向中國股市是在該行業大幅上漲之前做出的。但是,週一北京宣佈的措施未達到市場預期,漲勢步履蹣跚。

The investor's other notable holdings include The RealReal Inc., Olaplex Holdings Inc., and American Coastal Insurance Corp. BioAtla Inc., a clinical-stage biopharmaceutical company, also represents a smaller position in the portfolio.

該投資者的其他重要持股包括RealReal Inc.、Olaplex Holdings Inc.和處於臨床階段的生物製藥公司美國海岸保險公司BioAtla Inc.,在投資組合中的持倉也較小。

Earlier this year, Burry made headlines for substantial investments in gold and renewable energy while exiting positions in major U.S. tech companies like Amazon.com Inc. and Alphabet Inc..

今年早些時候,伯裏因大量投資黃金和可再生能源而成爲頭條新聞,同時退出了亞馬遜公司和Alphabet Inc.等美國主要科技公司的職位。

Investors should note that 13F reports, typically filed 45 days after each quarter's end, only disclose holdings in U.S. equity securities and do not provide information on the timing of purchases or sales, according to the SEC. While these reports offer valuable insights into market trends and institutional strategies, they represent a snapshot of holdings at a specific point in time.

投資者應注意,根據美國證券交易委員會的說法,13F報告通常在每個季度結束後45天提交,僅披露持有的美國股票,不提供有關購買或出售時間的信息。儘管這些報告提供了對市場趨勢和機構戰略的寶貴見解,但它們代表了特定時間點的持股概況。

  • US Stocks Set To Open Marginally Lower, Nvidia Gains, Traders Eye Fed Minutes: Strategist Predicts Many More Years Of Gains Ahead Of Bull Market's 2nd Anniversary

  • 美國股市開盤將小幅走低,英偉達上漲,交易員關注聯儲局會議紀要:策略師預測牛市兩週年前還將上漲多年

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免責聲明:此內容部分是在人工智能工具的幫助下製作的,並由Benzinga的編輯審閱和發佈。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論